𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen

✍ Scribed by Jason T. Schuman; Jeffrey S. Grinstead; Vasso Apostolopoulos; A. Patricia Campbell


Book ID
101719335
Publisher
Wiley (John Wiley & Sons)
Year
2005
Tongue
English
Weight
319 KB
Volume
77
Category
Article
ISSN
0006-3525

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

MUC1 mucin is a large transmembrane glycoprotein whose extracelluler domain is composed of repeating units of a 20 amino acid sequence. In the cancer associated state, this protein expression becomes upregulated and underglycosylated. Previous studies, which show an enhanced binding of a 5‐repeat over a 1‐repeat MUC1 peptide to a panel of anti‐MUC1 antibodies, have led us to investigate the structural and dynamic consequences of increasing repeat number. Two MUC1 peptides were studied: a 16mer corresponding to slightly less than one full repeat of the MUC1 tandem repeat sequence (GVTSAPDTRPAPGSTA) and a 40mer corresponding to two full repeats of the MUC1 sequence (VTSAPDTRPAPGSTAPPAHG)~2~. Isotopically labeled versions of these MUC1 peptides were cloned, expressed, purified, and evaluated structurally and dynamically using ^15^N‐ and ^13^C‐edited NMR approaches. The data show that MUC1 structure, dynamics, and antibody binding affinity are invariant with increasing repeat number. In light of these results, we conclude that the enhanced antibody affinity of the 5‐repeat over the 1‐repeat MUC1 peptide is due to multivalency effects, and not due to the development of higher order structure in the longer length peptides. The implications of these results are discussed within the context of a multiple repeat MUC1 breast cancer vaccine design. Β© 2005 Wiley Periodicals, Inc. Biopolymers, 2005


πŸ“œ SIMILAR VOLUMES


Expression of MUC1 and MUC2 mucin antige
✍ Michiyo Higashi; Suguru Yonezawa; Jenny J. L. Ho; Sadao Tanaka; Tatsuro Irimura; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 439 KB

Our previous immunohistochemical study on intrahepatic bile duct tumors showed that invasive cholangiocarcinoma (ICC) with a poor outcome expressed MUC1 mucin but was negative for MUC2 mucin, whereas bile duct cystadenocarcinoma (BDCC) with a favorable outcome was MUC1 negative and MUC2 positive. In